In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Are Medicare beneficiaries with knee osteoarthritis receiving enough conservative care?

By Marilynn Larkin NEW YORK (Reuters Health) - Non-surgical care for knee osteoarthritis is uncommon among older adults, especially in regions of the U.S. where total knee arthroplasty (TKA) rates are

Rituximab seems safe and effective for systemic sclerosis

By Marilynn Larkin NEW YORK (Reuters Health) - Rituximab seemed to be a safe and effective treatment for systemic sclerosis in a placebo-controlled validation trial in Japan. "A number of studies have

COVID-19 survivors may have loss of brain tissue

By Reuters Staff (Reuters) - Even mild cases of COVID-19 may lead to loss of brain tissue, according to findings from a long-term study involving 782 volunteers. As part of the ongoing UK Biobank

Most results from e-cigarette trials improperly reported, or not reported at all

By Linda Carroll (Reuters Health) - Of five clinical trials listed on and sponsored by JUUL Labs, only one resulted in a published paper and none had results posted on the

Disproportionate share of international medical graduates died from COVID-19 in U.S.

By Lisa Rapaport (Reuters Health) - In many states, a larger share of physicians trained outside the U.S. than their representation in the workforce died due to COVID-19, a recent study suggests.

Financial toxicity of having CVD worse than with cancer in U.S.

By Lisa Rapaport (Reuters Health) - American adults with atherosclerotic cardiovascular disease may experience greater financial toxicity than those with cancer, a U.S. study suggests. Researchers

One in six pregnant women delivering in a U.S. hospital may see a big bill, even with insurance

By Linda Carroll (Reuters Health) - For as many as one in six families who have private health insurance, there can be sticker shock when they see their portion of the bill for a hospital delivery, a

German lab, J&J still hashing out details of COVID-19 vaccine clot collaboration

By John Miller ZURICH (Reuters) - A scientist investigating rare blood clots possibly linked to AstraZeneca's and Johnson & Johnson's COVID-19 vaccines has yet to start a planned collaboration with

California launches digital COVID-19 vaccine pass but won't require it

By Paresh Dave OAKLAND, Calif. (Reuters) - California officials on Friday unveiled a website to access or download a digital copy of COVID-19 immunization records, though they stressed the state would

Delta COVID variant becoming globally dominant, WHO official says

By Reuters Staff GENEVA (Reuters) - The Delta variant of COVID-19, first identified in India, is becoming the globally dominant variant of the disease, the World Health Organization's chief scientist

ANALYSIS-Rival treatments may help justify FDA gamble with Biogen Alzheimer's drug

By Deena Beasley and Julie Steenhuysen (Reuters) - Data from clinical trials of three experimental Alzheimer's disease drugs expected to start emerging next year could help shed light on whether U.S.

COVID surges, but Russians resist coaxing and compulsion to get vaccinated

By Polina Nikolskaya and Anton Zverev MOSCOW (Reuters) - Seemingly lost for an explanation of why vaccine uptake is so low in Russia when coronavirus infections are soaring and vaccines are readily

UPDATE 1-Kremlin blames vaccine hesitancy as Delta variant drives Moscow surge

(Adds parliamentary voting extension in paragraph 10, restores date of June 2 in paragraph 9) By Reuters Staff MOSCOW (Reuters) - The Kremlin on Friday blamed a surge in COVID-19 cases on reluctance

Chemotherapy during pregnancy needn't harm the fetus

By David Douglas NEW YORK (Reuters Health) - Although chemotherapy within the first trimester of pregnancy is associated with an increased risk of major congenital malformations, treatment delay

CORRECTED-Kremlin blames vaccine hesitancy as Delta variant drives Moscow surge

(In paragraph 9, corrects date of latest vaccination tally to June 12, not June 2; updates headline) By Reuters Staff MOSCOW (Reuters) - The Kremlin on Friday blamed a surge in COVID-19 cases on

EXCLUSIVE-Google searches for new measure of skin tones to curb bias in products

By Paresh Dave (Reuters) - Alphabet Inc's Google told Reuters this week it is developing an alternative to the industry standard method for classifying skin tones, which a growing chorus of technology

In early lung cancer, immunotherapy plus targeted radiation may up response rate

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Patients with non-small-cell lung cancer (NSCLC) may respond more quickly to neoadjuvant durvalumab combined with stereotactic body radiotherapy

AI-enhanced ECG can help rapidly rule out COVID-19

By Reuters Staff NEW YORK (Reuters Health) - Artificial intelligence (AI)-enhanced electrocardiograms (ECGs) can detect subtle, subclinical electrical changes in the heart associated with SARS-CoV-2

Strict rest after sports concussion slows recovery, progressive moderate exercise helpful: experts

By Megan Brooks NEW YORK (Reuters Health) - Strict rest after a sports-related concussion slows recovery and may prolong symptoms, whereas progressive moderate aerobic exercise within the first week

Thailand scraps plan for 16-week dose gap on AstraZeneca vaccine

By Reuters Staff BANGKOK (Reuters) - Thailand has abandoned its plan for a 16-week gap between doses of the AstraZeneca coronavirus vaccine and will opt for a shorter interval of 10 to 12 weeks

S.Korea to mix-and-match COVID-19 vaccine doses for 760,000 people

By Sangmi Cha SEOUL (Reuters) - Some 760,000 South Koreans who have received a first dose of AstraZeneca Plc's COVID-19 vaccine will be offered Pfizer Inc's vaccine as a second shot due to shipment

Delta variant of coronavirus seen dominant in Germany by autumn

By Joseph Nasr BERLIN (Reuters) - The more infectious Delta coronavirus variant will become dominant in Germany by the autumn at the latest, the country's top public health official said on Friday,

Kremlin blames 'nihilism' as Moscow sees record COVID-19 infections

By Reuters Staff MOSCOW (Reuters) - The Kremlin on Friday blamed a surge in COVID-19 cases on "nihilism" and reluctance to have vaccinations after a record 9,056 new infections in Moscow, mostly with

India should brace for third COVID-19 wave by Oct, say health experts

By Shrutee Sarkar BENGALURU (Reuters) - A third wave of coronavirus infections is likely to hit India by October, and although it will be better controlled than the latest outbreak the pandemic will

'Ice' flavored e-cigarettes tied to nicotine dependence among young adults

By Lisa Rapaport (Reuters Health) - Young adults who use e-cigarettes with fruity "cooling" flavors like blueberry-ice and melon-ice may be at higher risk of nicotine dependence than vapers who favor

High-priority patients often don't make it to the kidney-transplant wait list

By Reuters Staff NEW YORK (Reuters Health) - Kidney transplantation is often the best option for people with end-stage kidney disease (ESKD), but many "high priority" patients are not placed on the

Polymyositis-dermatomyositis tied to arrhythmias in young, middle-aged adults

By Lisa Rapaport (Reuters Health) - Young and middle-aged adults with polymyositis-dermatomyositis are more likely to have arrhythmias in general, and supraventricular arrhythmias in particular, than

FACTBOX-Five Chinese scientists face U.S. visa fraud charges

By Jane Lanhee Lee (Reuters) - The United States Department of Justice in late 2018 launched the "China Initiative" to stem the theft of trade secrets by Chinese entities and keep technology developed

FOCUS-Chinese scientists ensnared in U.S. visa fraud legal battle

By Jane Lanhee Lee SAN FRANCISCO (Reuters) - For Chinese brain researcher Song Chen, a visiting scholar at Stanford University when she was arrested last July on a visa fraud charge, a court hearing

Drop in Havana COVID-19 cases boosts hopes Cuban vaccines working

By Sarah Marsh HAVANA (Reuters) - Coronavirus infections have halved in Havana since authorities started administering Cuba's experimental vaccines en masse in the capital a month ago, official data

Moscow facing new aggressive coronavirus variant, mayor says

By Tom Balmforth and Andrey Ostroukh MOSCOW (Reuters) - Moscow is facing a new coronavirus variant that is more aggressive and infectious, and the situation in the city is rapidly deteriorating, its

CureVac may let contractors make rival vaccines if own shot fails - CEO

By Tilman Blasshofer and Ludwig Burger FRANKFURT (Reuters) - German biotech firm CureVac could allow its network of manufacturing partners to be repurposed to make vaccines developed by other

No benefit to routine use of platinum agents after neoadjuvant chemo in triple-negative breast cancer

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with triple-negative breast cancer (TNBC) and residual invasive disease (RD), there is no benefit and more toxicity when platinum agents are

Cancer patients at high risk of death from COVID-19 identified

By Marilynn Larkin NEW YORK (Reuters Health) - Using real-world data, researchers identified characteristics of cancer patients at highest risk of mortality from COVID-19. "We set out to take

Former Swiss 'Magic Mountain' TB clinics treat COVID to stay relevant

By John Miller WALD/DAVOS, Switzerland (Reuters) - Swiss mountain sanatoriums whose fresh-air and sunlight cures once drew tuberculosis patients from across Europe are reinventing themselves for a new

UPDATE 1-European regulator EMA says it won't set 50% efficacy threshold for COVID shots

(Adds details, quotes) By Reuters Staff (Reuters) - The European Medicines Agency (EMA) said on Thursday it would not impose a 50% efficacy threshold for COVID-19 vaccines, adding full trial data was

OCT corneal epithelial mapping may help doctors better diagnose dry eye

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Optical coherence tomography (OCT) corneal epithelial mapping can help doctors better screen for and stage dry-eye disease (DED), new research

Pfizer's rheumatoid arthritis drug shows benefit in COVID-19 pneumonia

By Reuters Staff (Reuters) - Pfizer Inc said on Wednesday its oral rheumatoid arthritis drug Xeljanz reduced death or respiratory failure in hospitalized COVID-19 patients with pneumonia in Brazil,

COVID-19 cases surge in Africa, less than 0.8% of fully vaccinated, say officials

By Reuters Staff NAIROBI (Reuters) - COVID-19 cases rose by over 20% week-on-week in nearly two dozen African countries and progress on vaccinating Africans is proceeding slowly, with just 0.79% of

China disease expert says COVID-19 origins probe should shift to U.S.- Global Times

By Reuters Staff SHANGHAI (Reuters) - A senior Chinese epidemiologist said the United States should be the priority in the next phase of investigations into the origin of COVID-19 after a study showed

EMA says setting 50% efficacy threshold for COVID-19 vaccines is difficult

By Reuters Staff (Reuters) - The European Medicines Agency (EMA) said on Thursday it was not willing to impose a 50% efficacy threshold for COVID-19 vaccines, adding full trial data was necessary for

No benefit to post-op heparin bridging in patients who stop warfarin for a procedure

By Reuters Staff NEW YORK (Reuters Health) - There does not appear to be a benefit to postoperative heparin bridging in patients with atrial fibrillation or a mechanical heart valve who temporarily

Lipid management lacking in patients with peripheral-artery disease

By David Douglas NEW YORK (Reuters Health) - Lipid-lowering therapies aimed at reducing low-density-lipoprotein cholesterol (LDL-C) are underused, according to a study of more than a quarter of a

ECG biomarker identifies AFib patients most likely to benefit from electrical stimulation

By Brandon May NEW YORK (Reuters Health) - P-wave alternans (PWA) may act as a biomarker for identifying patients with atrial fibrillation (AF) who are most likely to benefit from chronic low-level

COVID-19 vaccine safe and effective in cancer patients on active treatment

By Reuters Staff NEW YORK (Reuters Health) - A new study confirms the safety and effectiveness of COVID-19 vaccines in adults with cancer receiving active treatment, a potentially vulnerable

U.S. Supreme Court rejects Republican challenge to Obamacare law

By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Thursday rejected a Republican bid that had been backed by former President Donald Trump's administration to invalidate the

Hundreds of vaccinated Indonesian health workers get COVID-19, dozens in hospital

By Kate Lamb, Agustinus Beo Da Costa and Stanley Widianto JAKARTA (Reuters) - More than 350 doctors and medical workers have caught COVID-19 in Indonesia despite being vaccinated with Sinovac and

Delta variant fuelled 50% rise in English COVID prevalence -study

By Reuters Staff LONDON (Reuters) - The rapid spread of the Delta coronavirus variant has driven a 50% rise in infections in England since May, a large prevalence study led by Imperial College London

Low dosage may be behind low efficacy of CureVac vaccine -study leader

By Caroline Copley BERLIN (Reuters) - The low dosage might be a key reason why CureVac's COVID-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study

Privacy may be at risk with medical and health apps

By Linda Carroll (Reuters Health) - Personal data may be at risk with many health and medical apps, a new study suggests. An in-depth analysis of more than 20,000 health related apps available through

Regeneron COVID-19 drug helps hardly-sick and very-sick patients

By Reuters Staff (Reuters) - An antibody cocktail from Regeneron Pharmaceuticals Inc and Roche showed benefits for a wide range of COVID-19 patients, from those without symptoms to hospitalized

Some lymph node cancers limit COVID-19 vaccine responses

By Reuters Staff (Reuters) - Some patients with lymph node cancers will have good antibody responses to COVID-19 vaccines, but others will need further protection, according to new data. The UK

Gut microbiome tied to non-social fear response in infants

By Marilynn Larkin NEW YORK (Reuters Health) - The composition of the gut microbiome is associated with how infants experience non-social fear - e.g., fear in response to someone wearing a mask

UPDATE 1-CureVac's COVID-19 vaccine misses efficacy goal in pivotal trial

(Adds trial details) By Reuters Staff (Reuters) - German biotech group CureVac said in a statement ( on Wednesday its mRNA-based COVID-19 vaccine was shown to be 47% effective

CureVac's COVID-19 vaccine misses efficacy goal in mass trial

By Reuters Staff (Reuters) - German biotech group CureVac said in a statement ( on Wednesday its mRNA-based COVID-19 vaccine was shown to be 47% effective against disease in a

Biomarkers pinpoint resistant prostate cancer that may benefit from addition of apalutamide

By Marilynn Larkin NEW YORK (Reuters Health) - Biomarkers can be used to identify patients with prostate cancer refractory to first-line androgen deprivation therapy (ADT) who might benefit from the

IVIG, glucocorticoids or both produce similar outcomes against MIS-C

By Gene Emery (Reuters Health) - A large international study has concluded that children who develop multisystem inflammatory syndrome (MIS-C) after infection with SARS-CoV-2 may derive comparable

Presumed sudden cardiac death among HIV-infected often not due to coronary-artery disease

By Gene Emery NEW YORK (Reuters Health) - People with HIV have a rate of sudden cardiac death that is more than double that in the non-infected population, according to a new study of cases in San

Therapeutic hypothermia offers no survival benefit for comatose patients after cardiac arrest

By Gene Emery NEW YORK (Reuters Health) - A large multinational study may cool enthusiasm for using hypothermia to treat comatose patients recovering from an out-of-hospital cardiac arrest. The test

Denmark sees surge in 'heart runners' after Eriksen's cardiac arrest

By Philip O'Connor COPENHAGEN (Reuters) - The cardiac arrest suffered by Denmark midfielder Christian Eriksen during a Euro 2020 match on Saturday has been followed by a seven-fold increase in

Supine hypertension tied to impaired cerebral oxygenation

By Lisa Rapaport (Reuters Health) - Older adults with supine hypertension are more likely to have an impaired blood pressure response to orthostasis as well as impaired cerebral oxygenation while

UPDATE 1-Regeneron's antibody therapy cuts deaths among some hospitalised COVID-19 patients -study

(Adds link to preprint) By Alistair Smout LONDON (Reuters) - A COVID-19 antibody cocktail developed by Regeneron Pharmaceuticals Inc and Roche reduced deaths in hospitalised patients whose own immune

Frequent snoring tied to increased asthma symptoms, health care use in kids

By Lisa Rapaport (Reuters Health) - Habitual snoring increases odds for maximum asthma symptom days and health care utilization in children with persistent asthma, a study of inner-city kids suggests.

COVID-19 vaccine access, not acceptance, key issue in Americas -PAHO

By Julia Symmes Cobb BOGOTA (Reuters) - The primary issue with lagging COVID-19 vaccinations in the Americas is access to doses, not acceptance of vaccine safety or efficacy, the Pan American Health

Novartis prostate cancer drug receives U.S. FDA breakthrough designation

By Reuters Staff ZURICH (Reuters) - Swiss drugmaker Novartis AG has received breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental treatment for advanced

U.S. buys 200 mln more Moderna COVID-19 vaccine doses

By Reuters Staff (Reuters) - The U.S. government has bought another 200 million doses of Moderna's COVID-19 vaccine, the drugmaker said on Wednesday, including an option to buy experimental shots that

England to make COVID-19 vaccinations compulsory for care workers

By Reuters Staff LONDON (Reuters) - It will be mandatory for care home workers in England to have coronavirus vaccinations, British health minister Matt Hancock said on Wednesday, adding the

EU approval of Russia's Sputnik V vaccine delayed, sources say

By Andreas Rinke and Emilio Parodi BERLIN (Reuters) - European Union approval of Russia's Sputnik V coronavirus vaccine will be delayed because a June 10 deadline to submit data was missed, two people

Moscow makes COVID-19 vaccination compulsory for public-facing workers

By Reuters Staff MOSCOW (Reuters) - City authorities in Moscow announced on Wednesday that all workers with public facing roles will be required to be vaccinated against COVID-19, one of the most

FACTBOX-Mexico's obesity epidemic

By Stefanie Eschenbacher and Carlos Jasso TEXCOCO, Mexico (Reuters) - Mexican girls and boys, but especially girls, have seen their mean body mass index (BMI) rise at one of the steepest rates

WIDER IMAGE-Temptation everywhere: Mexican children struggle with obesity

By Stefanie Eschenbacher and Carlos Jasso TEXCOCO, Mexico (Reuters) - Daniela was 11 years old when a doctor told her she would not live more than another six or seven years. Weighing 75 kilos (165 lb

High arrhythmic burden with left-bundle-branch block after TAVR with balloon-expandable valve

By Megan Brooks NEW YORK (Reuters Health) - Patients who develop left-bundle-branch block (LBBB) after transcatheter aortic-valve replacement (TAVR) using the SAPIEN 3 balloon-expandable heart valve

Choline PET-CT best preop imaging modality to localize primary hyperparathyroidism

By Reuters Staff NEW YORK (Reuters Health) - Choline positron-emission tomography and computed tomography (PET-CT) is the best imaging modality for preoperative of localization of primary

Improvements in ischemia and angina common in INOCA, but not correlated

By Lorraine L. Janeczko NEW YORK (Reuters Health) - In ischemia with no obstructive coronary-artery disease (INOCA), both ischemia and angina often get better over time, but the improvements may not

COVID-19 mRNA vaccination lymph node reactivity may be misinterpreted

By David Douglas NEW YORK (Reuters Health) - Ipsilateral axillary nodal reactivity commonly seen after the intramuscular administration of the COVID-19 mRNA vaccines may cause unnecessary concern,

Regeneron's antibody therapy cuts deaths among some hospitalised COVID-19 patients -study

By Alistair Smout LONDON (Reuters) - A COVID-19 antibody cocktail developed by Regeneron Pharmaceuticals Inc and Roche reduced deaths in hospitalised patients whose own immune systems had failed to

First patient set to receive controversial Biogen Alzheimer's drug

By Deena Beasley (Reuters) - A U.S. hospital on Wednesday will give the first infusion of an expensive, controversial new Alzheimer's drug from Biogen Inc before Medicare had even said what it will

Going directly to angiography tied to better outcomes after transfer for thrombectomy

By Lisa Rapaport (Reuters Health) - Transferred patients undergoing endovascular thrombectomy may receive faster treatment and have better functional outcomes when they go directly to angiography

Female gastroenterologists navigate range of pregnancy-related challenges

By Lisa Rapaport (Reuters Health) - Female gastroenterologists can encounter a wide range of pregnancy-related challenges in their careers, including the risk of radiation exposure as well as limited

Vicariously experienced racism leaves teens feeling helpless, but also spurs activism

By Linda Carroll (Reuters Health) - Interviews with teens reveal that vicarious exposure to racism via the media can lead to feelings of helplessness, but may also spark activism as a coping mechanism

Patient-provider discussions about bariatric surgery beneficial, but rare

By Marilynn Larkin NEW YORK (Reuters Health) - Fewer than 10% of potentially eligible patients have conversations with their healthcare providers about bariatric surgery, yet those who do are more

Nitrous oxide promising for treatment-resistant depression

By Marilynn Larkin NEW YORK (Reuters Health) - Inhaled nitrous oxide (N2O) at a concentration of 25% effectively treated depressive symptoms for up to two weeks in a phase 2 trial. The concentration

EU wants faster vaccine production in 'age of pandemics'

By Reuters Staff BRUSSELS (Reuters) - The European Union plans to boost its early warning system and have a permanent capacity to produce about 300 million vaccines in the first six months of any new

REFILE-Five U.S. states had coronavirus infections even before first reported cases -study

(Removes repeated mention of journal name in paragraph 9) By Mrinalika Roy (Reuters) - At least seven people in five U.S. states were infected with the novel coronavirus weeks before those states

Pioneering space reproduction research yields healthy baby mice

By Will Dunham (Reuters) - Trail-blazing space reproduction research that yielded healthy baby mice produced using freeze-dried sperm stored for years in orbit is showing the possibilities of

Five U.S. states had coronavirus infections even before first reported cases -study

By Mrinalika Roy (Reuters) - At least seven people in five U.S. states were infected with the novel coronavirus weeks before those states reported their first cases, a large new government study

CGRP monoclonal antibodies blurring the line between migraine prevention and treatment

By Megan Brooks NEW YORK (Reuters Health) - Eptinezumab, an intravenous anti-calcitonin gene-related peptide (CGRP) antibody approved in the U.S. for migraine prevention, is effective when initiated

INSIGHT-Health experts say India missed early alarm, let deadly coronavirus variant spread

By Devjyot Ghoshal and Zeba Siddiqui NEW DELHI (Reuters) - A veteran public health expert warned top Indian officials in early March that a new variant of the coronavirus was spreading quickly in a

Patients with advanced liver cancer prefer atezolizumab combo

By David Douglas NEW YORK (Reuters Health) - Patients with unresectable hepatocellular carcinoma report that quality of life, functioning and disease symptoms are improved with atezolizumab plus

Radical prostatectomy shifting to higher-risk cases in era of active surveillance

By Megan Brooks NEW YORK (Reuters Health) - There has been a trend towards decreasing use of radical prostatectomy (RP) in men with low- and favorable-intermediate-risk prostate cancer and increasing

Lipophilic statins may raise risk of conversion from MCI to dementia

By Megan Brooks NEW YORK (Reuters Health) - Among patients with early mild cognitive impairment (eMCI) and low to moderate serum cholesterol levels, those who take lipophilic statins have more than

Screening uptake, not biology, behind higher risk of colon cancer in Black people

By Megan Brooks NEW YORK (Reuters Health) - The reported higher risk of colorectal cancer (CRC) in African Americans compared to whites is likely not related to biology but rather to uptake of CRC

Social network for doctors Doximity targets $4 bln valuation in U.S. IPO

By Reuters Staff (Reuters) - Doximity Inc, a social network for doctors, is looking to raise nearly $536 million through a U.S. initial public offering, targeting a valuation of about $4 billion,

Novavax says efficacy preserved in participants receiving influenza, COVID-19 vaccines

By Reuters Staff (Reuters) - Novavax Inc said on Monday vaccine efficacy appeared to be preserved in those receiving an approved influenza vaccine along with its COVID-19 vaccine candidate compared to

Astra antibody cocktail fails to prevent COVID-19 symptoms in large trial

By Vishwadha Chander and Ludwig Burger (Reuters) - AstraZeneca said on Tuesday a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an

Adjuvant likely bests salvage radiation in high-risk prostate cancer

By Marilynn Larkin NEW YORK (Reuters Health) - Adjuvant radiation following radical prostatectomy (RP) seemed more effective in reducing all-cause mortality (ACM) than salvage radiation in men with

More obese, diabetic, chronically ill kids hospitalized with COVID-19

By Ronnie Cohen (Reuters Health) - Children with diabetes, obesity and cardiac and circulatory congenital anomalies were more likely to be hospitalized with COVID-19 and to be severely ill during

Percentage of high schoolers who identify as non-heterosexual rose in recent years

By Linda Carroll (Reuters Health) - Between 2015 and 2019, the prevalence of non-heterosexual identity increased by more than 41% in U.S. high school students, a new study finds. An analysis of survey

Filgotinib 200mg safe, effective for moderate to severe ulcerative colitis

By Lisa Rapaport (Reuters Health) - A 200-mg dose of filgotinib helped significantly more patients with ulcerative colitis than placebo to achieve clinical remission in a trial among individuals with

Aortic dissection tied to worse outcomes in women than men

By Marilynn Larkin NEW YORK (Reuters Health) - Women with type A acute aortic dissection (TAAD) were more likely to present late, with complications, and die in the hospital than men in an

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.

© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information